BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 97 filers reported holding BRIDGEBIO PHARMA INC in Q1 2020. The put-call ratio across all filers is 0.20 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $30,156,005 | +3930.0% | 1,143,613 | +2529.4% | 0.02% | – |
Q2 2023 | $748,294 | -56.8% | 43,493 | -58.4% | 0.00% | -100.0% |
Q1 2023 | $1,731,561 | +1544.4% | 104,468 | +655.5% | 0.00% | – |
Q4 2022 | $105,303 | -23.2% | 13,828 | -50.0% | 0.00% | – |
Q3 2022 | $137,137 | +7.1% | 27,658 | +96.6% | 0.00% | – |
Q2 2022 | $128,000 | -9.2% | 14,066 | +1.6% | 0.00% | – |
Q1 2022 | $141,000 | -39.0% | 13,848 | -0.1% | 0.00% | – |
Q4 2021 | $231,000 | -99.8% | 13,862 | -99.5% | 0.00% | -100.0% |
Q3 2021 | $123,992,000 | -27.6% | 2,645,441 | -5.9% | 0.05% | -26.0% |
Q2 2021 | $171,337,000 | -3.2% | 2,810,652 | -2.2% | 0.07% | -9.9% |
Q1 2021 | $176,988,000 | +39.6% | 2,873,183 | +61.1% | 0.08% | +37.3% |
Q4 2020 | $126,827,000 | +99.8% | 1,783,535 | +5.4% | 0.06% | +78.8% |
Q3 2020 | $63,464,000 | +10.2% | 1,691,461 | -4.2% | 0.03% | +3.1% |
Q2 2020 | $57,585,000 | +11.2% | 1,765,864 | -1.1% | 0.03% | -11.1% |
Q1 2020 | $51,795,000 | -53.0% | 1,786,039 | -43.1% | 0.04% | -35.7% |
Q4 2019 | $110,095,000 | +1034.1% | 3,141,081 | +594.7% | 0.06% | +1020.0% |
Q3 2019 | $9,708,000 | +4.0% | 452,171 | +30.7% | 0.01% | 0.0% |
Q2 2019 | $9,331,000 | – | 345,989 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 6,068,125 | $55,099,000 | 39.31% |
M28 Capital Management LP | 466,200 | $4,233,000 | 4.74% |
Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $282,034,000 | 3.75% |
Octagon Capital Advisors LP | 933,743 | $8,478,000 | 2.26% |
VIKING GLOBAL INVESTORS LP | 26,620,991 | $241,719,000 | 1.11% |
HHLR ADVISORS, LTD. | 5,362,014 | $48,687,000 | 1.04% |
Cormorant Asset Management, LP | 1,469,179 | $13,340,000 | 1.01% |
Knott David M Jr | 213,206 | $1,936,000 | 0.81% |
Fernwood Investment Management, LLC | 183,900 | $1,670,000 | 0.72% |
HighVista Strategies LLC | 105,942 | $962,000 | 0.58% |